These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10151029)

  • 21. Benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic alternatives in benign prostatic hyperplasia].
    Isa Kroon WA; Robles García JE
    Med Clin (Barc); 1993 Jun; 101(2):64-6. PubMed ID: 7685459
    [No Abstract]   [Full Text] [Related]  

  • 23. Future directions in the management of benign prostatic hyperplasia.
    Khoury S
    Br J Urol; 1992 Nov; 70 Suppl 1():27-32. PubMed ID: 1281730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical innovations in the treatment of benign prostatic hyperplasia: towards new standard treatments?].
    Cornu JN; Rouprêt M
    Prog Urol; 2007 Sep; 17(5 Suppl 1):1026-8. PubMed ID: 17969784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost aspects of transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization.
    van Melick HH; van Venrooij GE; van Swol CF; Boon TA
    Urology; 2004 May; 63(5):882-6. PubMed ID: 15134971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New trends in the treatment of benign prostatic hyperplasia and carcinoma of the prostate.
    Petrovich Z; Ameye F; Baert L; Bichler KH; Boyd SD; Brady LW; Bruskewitz RC; Dixon C; Perrin P; Watson GM
    Am J Clin Oncol; 1993 Jun; 16(3):187-200. PubMed ID: 7687817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH).
    Punekar SV; Kelkar AR; Gavande PM; Rao NR; Date JA; Prem AR
    J Postgrad Med; 1995; 41(4):99-101. PubMed ID: 10707729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Minimal invasive therapy of benign prostatic hyperplasia].
    Madersbacher S; Marberger M
    Wien Med Wochenschr; 1996; 146(8):169-75. PubMed ID: 8767402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign prostatic hyperplasia: a review.
    Ramsey EW
    Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BPH: costs and treatment outcomes.
    Nickel JC
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S141-8. PubMed ID: 16613528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment and pharmacologic management of BPH in the context of common comorbidities.
    O'Leary MP
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S129-40. PubMed ID: 16613527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
    Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
    BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Many therapeutic alternatives in prostatic hyperplasia. TUMT is not so effective as TURP, but better than drug therapy].
    Ekman P
    Lakartidningen; 1999 Aug; 96(34):3504-5. PubMed ID: 10492548
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment options for benign prostatic hyperplasia in older men.
    Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
    Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Benign hyperplasia of the prostate: an overview of the treatment options].
    Elhilali MM; Hamdy SM
    Prog Urol; 1992 Dec; 2(6):949-70. PubMed ID: 1284555
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of benign prostatic hyperplasia by the primary care physician in the 21st century: the new paradigm.
    Barkin J
    Can J Urol; 2008 Aug; 15 Suppl 1():21-30; discussion 30. PubMed ID: 18700062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign prostatic hyperplasia. Medical and minimally invasive treatment options.
    Oesterling JE
    N Engl J Med; 1995 Jan; 332(2):99-109. PubMed ID: 7527494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.